Sweden · Delayed Price · Currency is SEK Bioextrax AB Statistics
Total Valuation
Bioextrax AB has a market cap or net worth of SEK 135.08 million. The enterprise value is 122.94 million.
| Market Cap | 135.08M |
| Enterprise Value | 122.94M |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Bioextrax AB has 39.73 million shares outstanding. The number of shares has increased by 30.38% in one year.
| Current Share Class | 39.73M |
| Shares Outstanding | 39.73M |
| Shares Change (YoY) | +30.38% |
| Shares Change (QoQ) | +6.39% |
| Owned by Insiders (%) | 18.17% |
| Owned by Institutions (%) | 18.64% |
| Float | 31.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 142.34 |
| PB Ratio | 6.12 |
| P/TBV Ratio | 6.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.47 |
| EV / Sales | 129.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.68 |
Financial Position
The company has a current ratio of 8.21
| Current Ratio | 8.21 |
| Quick Ratio | 7.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8,319.00 |
Financial Efficiency
Return on equity (ROE) is -87.20% and return on invested capital (ROIC) is -55.11%.
| Return on Equity (ROE) | -87.20% |
| Return on Assets (ROA) | -51.84% |
| Return on Invested Capital (ROIC) | -55.11% |
| Return on Capital Employed (ROCE) | -75.38% |
| Revenue Per Employee | 67,786 |
| Profits Per Employee | -1.18M |
| Employee Count | 14 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.49 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 3.02 |
| 200-Day Moving Average | 3.04 |
| Relative Strength Index (RSI) | 59.18 |
| Average Volume (20 Days) | 71,041 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioextrax AB had revenue of SEK 949,000 and -16.45 million in losses. Loss per share was -0.46.
| Revenue | 949,000 |
| Gross Profit | -391,000 |
| Operating Income | -16.64M |
| Pretax Income | -16.45M |
| Net Income | -16.45M |
| EBITDA | -15.50M |
| EBIT | -16.64M |
| Loss Per Share | -0.46 |
Balance Sheet
The company has 12.14 million in cash and n/a in debt, giving a net cash position of 12.14 million or 0.31 per share.
| Cash & Cash Equivalents | 12.14M |
| Total Debt | n/a |
| Net Cash | 12.14M |
| Net Cash Per Share | 0.31 |
| Equity (Book Value) | 22.07M |
| Book Value Per Share | 0.56 |
| Working Capital | 12.56M |
Cash Flow
In the last 12 months, operating cash flow was -18.18 million and capital expenditures -215,000, giving a free cash flow of -18.40 million.
| Operating Cash Flow | -18.18M |
| Capital Expenditures | -215,000 |
| Free Cash Flow | -18.40M |
| FCF Per Share | -0.46 |
Margins
| Gross Margin | -41.20% |
| Operating Margin | -1,753.21% |
| Pretax Margin | -1,733.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Bioextrax AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.38% |
| Shareholder Yield | n/a |
| Earnings Yield | -12.18% |
| FCF Yield | -13.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 22, 2021. It was a forward split with a ratio of 4.
| Last Split Date | Jul 22, 2021 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Bioextrax AB has an Altman Z-Score of 37.68.
| Altman Z-Score | 37.68 |
| Piotroski F-Score | n/a |